While cytarabine is effective, it carries the risk of severe complications. High-dose cytarabine (HiDAC) therapy can lead to neurotoxicity, manifesting as cerebellar dysfunction, which affects coordination and balance. Other serious risks include hepatotoxicity (liver damage) and pulmonary toxicity (lung damage). Close monitoring and supportive care are crucial to manage these potential complications.
